BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 34415233)

  • 1. Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs.
    Parlakpinar H; Gunata M
    Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):651-665. PubMed ID: 34415233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin inhibitors in renal transplantation: what is the best option?
    Tanabe K
    Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current State of Immunosuppression: Past, Present, and Future.
    Karam S; Wali RK
    Crit Rev Eukaryot Gene Expr; 2015; 25(2):113-34. PubMed ID: 26080606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression and Heart Transplantation.
    Sutaria N; Sylvia L; DeNofrio D
    Handb Exp Pharmacol; 2022; 272():117-137. PubMed ID: 34671867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapies in transplantation.
    Jorga A; Johnston A
    Expert Opin Investig Drugs; 2005 Mar; 14(3):295-304. PubMed ID: 15833060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic immunosuppressants.
    Medeiros M; Lumini J; Stern N; Castañeda-Hernández G; Filler G
    Pediatr Nephrol; 2018 Jul; 33(7):1123-1131. PubMed ID: 28733752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of tacrolimus-based immunosuppression after heart or lung transplantation.
    Reichenspurner H
    J Heart Lung Transplant; 2005 Feb; 24(2):119-30. PubMed ID: 15701425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
    Chang SH; Russ GR; Chadban SJ; Campbell S; McDonald SP
    Nephrology (Carlton); 2008 Apr; 13(2):171-6. PubMed ID: 18275507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressants in Organ Transplantation.
    Tönshoff B
    Handb Exp Pharmacol; 2020; 261():441-469. PubMed ID: 31820175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin inhibitors in pediatric renal transplant recipients.
    Filler G
    Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum.
    Tredger JM; Brown NW; Dhawan A
    Drugs; 2008; 68(10):1385-414. PubMed ID: 18578558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of complications from use of conventional immunosuppressants: a critical review.
    Ponticelli C; Glassock RJ
    J Nephrol; 2019 Dec; 32(6):851-870. PubMed ID: 30927190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapy post-transplantation in children: what the clinician needs to know.
    Tönshoff B
    Expert Rev Clin Immunol; 2020 Feb; 16(2):139-154. PubMed ID: 31952458
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppressive Therapy in Transplantation.
    Allison TL
    Nurs Clin North Am; 2016 Mar; 51(1):107-20. PubMed ID: 26897428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database.
    Tsai SF; Cheng CY; Shu KH; Wu MJ
    Transplant Proc; 2012 Jan; 44(1):190-2. PubMed ID: 22310612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the immunosuppressive regimen in heart transplantation.
    Eisen H; Ross H
    J Heart Lung Transplant; 2004 May; 23(5 Suppl):S207-13. PubMed ID: 15093807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation.
    Wong TC; Lo CM; Fung JY
    Expert Opin Emerg Drugs; 2017 Jun; 22(2):123-136. PubMed ID: 28503959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.